Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Federman & Sherwood
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.
August 18th, 2007
On July 13, 2007, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Bioenvision, Inc. (NASDAQ:BIVN). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price. The class period is from May 1, 2007 through May 28, 2007. Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than Tuesday,...
Source: Law & Health Weekly (2007-08-18)
|
